Cumberland Pharmaceuticals (CPIX) Debt to Equity: 2009-2025
Historic Debt to Equity for Cumberland Pharmaceuticals (CPIX) over the last 15 years, with Sep 2025 value amounting to $0.20.
- Cumberland Pharmaceuticals' Debt to Equity fell 69.10% to $0.20 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.19, marking a year-over-year decrease of 51.83%. This contributed to the annual value of $0.67 for FY2024, which is 54.79% up from last year.
- Cumberland Pharmaceuticals' Debt to Equity amounted to $0.20 in Q3 2025, which was up 7.16% from $0.19 recorded in Q2 2025.
- In the past 5 years, Cumberland Pharmaceuticals' Debt to Equity ranged from a high of $0.67 in Q4 2024 and a low of $0.18 during Q1 2025.
- Its 3-year average for Debt to Equity is $0.42, with a median of $0.43 in 2023.
- In the last 5 years, Cumberland Pharmaceuticals' Debt to Equity soared by 80.86% in 2024 and then tumbled by 69.34% in 2025.
- Cumberland Pharmaceuticals' Debt to Equity (Quarterly) stood at $0.35 in 2021, then grew by 27.50% to $0.45 in 2022, then dropped by 3.32% to $0.43 in 2023, then spiked by 54.79% to $0.67 in 2024, then tumbled by 69.10% to $0.20 in 2025.
- Its Debt to Equity stands at $0.20 for Q3 2025, versus $0.19 for Q2 2025 and $0.18 for Q1 2025.